Continued geopolitical tensions, groundbreaking generative AI, and critical climate changes have defined the past year of 2023. The official declaration of the end of the COVID-19 pandemic by the World Health Organization signals a return to normal operations for many parts of the world. Regional conflicts such as the Russo-Ukrainian war and the Israeli-Palestinian conflict have contributed to global instability. The impact of generative AI on business and society is reshaping the way people work and live. 2023 will be a year characterized by instability and transformation. Despite this, Browiner never stops moving forward.
As we conclude this year and look ahead to 2024 and beyond, we invite you to join Browiner in reflecting on our progress in 2023.
Innovation drives productivity
In 2023, Browiner introduced a range of groundbreaking and innovative products. The dynamic ceiling-suspended DR has transformed radiology productivity, enabling swift and precise diagnoses in busy examination settings. The launch of the ManntiX marks the advent of a new era for portable X-ray systems, integrating the tube head and workstation into one unit. This advancement sets a new standard for portability and ease of use, allowing imaging of all body parts, anytime, anywhere. The MobileApex elevates mobile radiography with its 63kW high power and multi-functional remote control system. Moving forward, Browiner will maintain its focus on meeting customer needs, exploring innovative imaging technology, and providing physicians with a more diverse imaging reference for diagnosis.
Active participation in charity campaigns
Browiner actively participates in primary healthcare and is committed to improving medical welfare in underdeveloped areas. We are engaged in constructing primary medical care facilities and our multi-scenario solutions aim to enhance the intelligent and standardized development of community and rural medical and health institutions. Through its intelligent medical solutions, Browiner empowers thousands of villages to improve primary healthcare.
Production capacity expansion
In October, the production ceremony of the Guizhou base was successfully held in Guiyang, marking a new phase of Browiner’s development. The official operation of the Guizhou factory underscores Browiner’s targeted efforts in expanding its production capacity, which will stimulate new industrial vitality and promote the integration of "research, production, and city".
Global installation continues to increase
In 2023, Browiner is experiencing global growth, with product installations reaching unprecedented levels. This demonstrates that Browiner's products are gaining recognition and support from a larger customer base. We are thrilled to establish strategic partnerships with an increasing number of customers to jointly enhance the quality of radiographic imaging services. Browiner is excited to expand our product reach in the global market and deliver top-notch clinical imaging experiences to a greater number of patients.
Shining at international exhibitions
Browiner has been actively seeking close communication with customers. In 2023, Browiner products were showcased at major international exhibitions and professional radiology conferences such as MEDICA, ECR, and RSNA, drawing experts and visitors to gather at the booth for in-depth interaction and communication with international medical professionals. In the future, we will continue to actively participate in international exhibitions and conferences to engage with global medical professionals, sparking innovation and knowledge and focusing on cutting-edge imaging technology.
Looking back on 2023, Browiner has made significant new advancements. As we move forward to 2024, Browiner will push the boundaries of exploration and strive to usher in a new era of imaging. Anticipate even more exciting surprises that Browiner will unveil for you.
